The future of the weight loss drug Meridia is still unclear.
A panel of experts has differing opinions on whether or not the drug should be pulled from the market.
A study out earlier this year found in overweight people who have cardiovascular problems, like diabetes or heart disease, Meridia raised their risk of heart attack or stroke 16 percent.
News 3 Medical Contributor Dr. Alan Xenakis says he hopes the FDA does pull Meridia off the market and raise awareness about these weight loss drugs.
"Weight loss drugs by definition will always have side effects," Xenakis said. "The problem is-- do they have side effects that outweigh the benefits? In my opinion no.
"It's great that the FDA is finally standing up, for the first time in history, in my opinion, after looking at the data without public opinion and saying, lets take a look at some of these weight loss drugs," Xenakis said. "They are not doing the kinds of things they should for our patients."
Meridia's fate is now in the hands of the FDA.
The agency will take the advisory panel's recommendation into consideration when it makes a final decision in the coming weeks.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.